Published in J Virol on January 01, 1975
Origin of the polyoma virus-associated endonuclease. J Virol (1975) 1.92
Interrupting the early region of polyoma virus DNA enhances tumorigenicity. Proc Natl Acad Sci U S A (1979) 1.45
Use of a restriction endonuclease in analyzing the genomes from two different strains of vaccinia virus. J Virol (1976) 1.17
Simian virus 40 DNA replication: characterization of gaps in the termination region. J Virol (1976) 1.02
The relationship of SV40 replicating chromosomes to two forms of the non-replicating SV40. Nucleic Acids Res (1978) 0.97
Mapping of the three species of polyoma mRNA. Proc Natl Acad Sci U S A (1976) 0.96
Measurements of the genome sizes of simian virus 40 and polyoma virus. J Virol (1977) 0.87
Polyoma viruses with mutations at endonuclease HindII site 1: alterations at the COOH terminus of VP1. J Virol (1979) 0.86
Denaturation map of polyoma DNA. J Virol (1975) 0.78
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
A restriction enzyme from Hemophilus influenzae. I. Purification and general properties. J Mol Biol (1970) 19.69
Specific cleavage of simian virus 40 DNA by restriction endonuclease of Hemophilus influenzae. Proc Natl Acad Sci U S A (1971) 10.06
Studies of simian virus 40 DNA. VII. A cleavage map of the SV40 genome. J Mol Biol (1973) 9.30
Cleavage of adenovirus type 2 DNA into six unique fragments by endonuclease R-RI. Proc Natl Acad Sci U S A (1973) 7.75
Polyoma DNA: a physical map. Proc Natl Acad Sci U S A (1974) 7.36
Quantitation of Simian virus 40 sequences in African green monkey, mouse and virus-transformed cell genomes. J Mol Biol (1971) 7.10
Structure of replicating simian virus 40 deoxyribonucleic acid molecules. J Virol (1971) 6.74
Specific endonuclease R fragments of bacteriophage phiX174 deoxyribonucleic acid. J Virol (1972) 5.98
A map of simian virus 40 transcription sites expressed in productively infected cells. J Mol Biol (1973) 5.02
Studies of mouse polyoma virus infection. 1. Procedures for quantitation and detection of virus. J Exp Med (1959) 3.37
Recovery of S35 radioactivity from protein-bearing polyacrylamide gel. Anal Biochem (1965) 2.87
The replication of polyoma DNA. J Gen Virol (1973) 2.26
Isolation and partial characterization of different defective DNA molecules derived from polyoma virus. J Virol (1974) 1.50
Use of restriction endonucleases in analyzing the genome of simian virus 40. Fed Proc (1974) 0.82
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science (1989) 7.90
Structure of replicating simian virus 40 deoxyribonucleic acid molecules. J Virol (1971) 6.74
Origin and direction of simian virus 40 deoxyribonucleic acid replication. J Virol (1972) 6.39
The effect of bedside case presentations on patients' perceptions of their medical care. N Engl J Med (1997) 4.63
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med (1995) 4.06
Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science (1987) 4.02
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J Virol (1997) 3.64
Intermediate in SV40 DNA chain growth. Nat New Biol (1972) 3.38
Resolutions and identification of the core deoxynucleoproteins of the simian virus 40. Biochem Biophys Res Commun (1973) 2.90
Sequential protein synthesis following vaccinia virus infection. J Virol (1968) 2.89
PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol (1994) 2.68
Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med (1990) 2.65
Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals. J Virol (1989) 2.62
Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J Infect Dis (1994) 2.60
Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis (1999) 2.52
Inhibition in the joining of DNA intermediates to growing simian virus 40 chains. J Virol (1973) 2.44
JC virus enhancer-promoter active in human brain cells. Science (1984) 2.36
Sequential formation of vaccinia virus proteins and viral deoxyribonucleic acid replication. J Virol (1967) 2.34
Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA. Cell (1982) 2.32
Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection. Mol Biol Evol (1999) 2.32
Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Ophthalmology (1999) 2.00
Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology (2000) 1.96
Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res (2000) 1.95
Simian virus 40 major late promoter: an upstream DNA sequence required for efficient in vitro transcription. Mol Cell Biol (1984) 1.94
Interpretation of the doublet at 850 and 830 cm-1 in the Raman spectra of tyrosyl residues in proteins and certain model compounds. Biochemistry (1975) 1.75
The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol Cell Biol (2001) 1.70
Metabolic properties of early and late vaccinia virus messenger ribonucleic acid. J Virol (1967) 1.70
Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene. J Virol (2000) 1.69
Specific initiation site for simian virus 40 deoxyribonucleic acid replication. J Virol (1972) 1.66
Isolation and characterization of six different chicken actin genes. Mol Cell Biol (1984) 1.63
The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity (1995) 1.63
Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB. Eur Respir J (1999) 1.60
Novel chicken actin gene: third cytoplasmic isoform. Mol Cell Biol (1985) 1.57
The complete sequence of the chicken alpha-cardiac actin gene: a highly conserved vertebrate gene. Nucleic Acids Res (1985) 1.55
Activation of the hypothalamus characterizes the acupuncture stimulation at the analgesic point in human: a positron emission tomography study. Neurosci Lett (2001) 1.54
Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport. J Virol (1989) 1.53
Single and multiple pyogenic liver abscesses: clinical course, etiology, and results of treatment. World J Surg (1997) 1.52
Simian virus 40 guanine-cytosine-rich sequences function as independent transcriptional control elements in vitro. Mol Cell Biol (1984) 1.52
Envelope-specific antibodies in the saliva of individuals vaccinated with recombinant HIV-1 gp160. J Acquir Immune Defic Syndr (1992) 1.49
Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J Biol Chem (1996) 1.47
Acute hemodynamic improvement by thermal vasodilation in congestive heart failure. Circulation (1995) 1.46
The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter. Mol Cell Biol (1998) 1.46
Unwinding of parental strands during simian virus 40 DNA replication. J Virol (1973) 1.43
The SV40 DNA template for transcription of late mRNA in viral nucleoprotein complexes. Cell (1977) 1.42
Characterization of Simian virus 40 DNA component II during viral DNA replication. J Mol Biol (1973) 1.40
Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer (2000) 1.39
Biochemical changes in phytohemagglutinin stimulated human lymphocytes. Exp Cell Res (1966) 1.39
In vitro transcription initiation by purified RNA polymerase II within the adenovirus 2 major late promoter region. J Biol Chem (1984) 1.38
Isolation and characterization of polyoma virus mutants which grow in murine embryonal carcinoma and trophoblast cells. EMBO J (1982) 1.38
Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. J Natl Cancer Inst (1974) 1.38
Occurrence and properties of a chromatin-associated F1-histone phosphokinase in mitotic Chinese hamster cells. Biochemistry (1972) 1.38
Passive hemagglutination test for detection of antibodies to human immunodeficiency virus type 1 and comparison of the test with enzyme-linked immunosorbent assay and Western blot (immunoblot) analysis. J Clin Microbiol (1989) 1.36
Superhelix density of replicating simian virus 40 DNA molecules. J Mol Biol (1974) 1.34
Chemical modification of simian virus 40 DNA by reaction with a water-soluble carbodiimide. J Virol (1976) 1.31
Proximal and distal domains that control in vitro transcription of the adenovirus IVa2 gene. Proc Natl Acad Sci U S A (1984) 1.30
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitors. Virology (1992) 1.29
Mapping of transcription sites of simian virus 40-specific late 16S and 19S mRNA by electron microscopy. Proc Natl Acad Sci U S A (1977) 1.28
Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes (2000) 1.27
PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J Exp Med (1995) 1.26
Effects of electromagnetic stimuli on bone and bone cells in vitro: inhibition of responses to parathyroid hormone by low-energy low-frequency fields. Proc Natl Acad Sci U S A (1982) 1.26
Primary angioplasty in acute inferior myocardial infarction with anomalous-origin right coronary arteries as infarct-related arteries: focus on anatomic and clinical features, outcomes, selection of guiding catheters and management. J Invasive Cardiol (2001) 1.25
Properties of simian virus 40 transcriptional intermediates isolated from nuclei of permissive cells. J Virol (1977) 1.25
Membrane permeabilization by small hydrophobic nonstructural proteins of Japanese encephalitis virus. J Virol (1999) 1.25
Persistence of four related human immunodeficiency virus subtypes during the course of zidovudine therapy: relationship between virion RNA and proviral DNA. J Virol (1994) 1.25
Laser-excited Raman spectroscopy of biomolecules. VI. Some polypeptides as conformational models. J Am Chem Soc (1974) 1.23
DNA probe detection of periodontal pathogens. Oral Microbiol Immunol (1986) 1.22
Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. J Virol (1989) 1.21
Efficient transcription of a compact nucleoprotein complex isolated from purified simian virus 40 virions. J Virol (1980) 1.21
Diversity of envelope antigens on murine type-C RNA viruses. J Natl Cancer Inst (1974) 1.20
Characterization of simian virus 40 tsA58 transcriptional intermediates at restrictive temperatures: relationship between DNA replication and transcription. J Virol (1977) 1.20
Randomized comparison of local versus epidural anesthesia for tension-free vaginal tape operation. J Urol (2001) 1.17
Regulation of simian virus 40 early and late gene transcription without viral DNA replication. J Virol (1979) 1.14
Separation of isolated Chinese hamster metaphase chromosomes into three size-groups. J Mol Biol (1968) 1.14
Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis (1997) 1.14
Mapping 5' termini of JC virus late RNA. J Virol (1986) 1.13
F1-histone modification at metaphase in Chinese hamster cells. Exp Cell Res (1972) 1.11
Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology (1991) 1.11
Increased TNF-alpha, IL-1 beta and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis. Tuber Lung Dis (1999) 1.11
Hin D restriction mapping of upaired regions in simian virus 40 superhelical DNA I: considerations regarding structure-function relationships. J Virol (1976) 1.10
Characterization of the 5'-terminal structure of simian virus 40 early mRNA's. J Virol (1979) 1.10
Surgical treatment of cholangiocarcinoma. Hepatogastroenterology (1997) 1.09
Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene (1998) 1.08
Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway. J Biol Chem (1999) 1.08
Preferential stimulation of transcription from simian virus 40 late and adeno IVa2 promoters in a HeLa cell extract. J Biol Chem (1983) 1.08
Giant Lambl's excrescences of papillary muscle and aortic valve: echocardiographic, angiographic, and pathologic findings. Clin Cardiol (1981) 1.07
Prognostic factors for pyogenic abscess of the liver. J Am Coll Surg (1994) 1.07
Raman spectra and structure of yeast phenylalanine transfer RNA in the crystalline state and in solution. Biochemistry (1975) 1.07
Postoperative morbidity and mortality of pancreaticoduodenectomy for periampullary cancer. Eur J Surg (1996) 1.06
Malignant change of juvenile polyp of colon: a case report. Chin Med J (Engl) (1978) 1.04
Sonographic features of small-bowel intussusception in pediatric patients. Acad Emerg Med (2001) 1.04
Selective degradation of newly synthesized nonmessenger simian virus 40 transcripts. J Virol (1978) 1.03
Inhibition of vasoconstriction by tetramethylpyrazine: does it act by blocking the voltage-dependent Ca channel? J Cardiovasc Pharmacol (1990) 1.03
Late replicative intermediates are accumulated during simian virus 40 DNA replication in vivo and in vitro. J Virol (1979) 1.03
Characterization of a surrogate TATA box promoter that regulates in vitro transcription of the simian virus 40 major late gene. Mol Cell Biol (1985) 1.03
Simian virus 40 DNA replication: characterization of gaps in the termination region. J Virol (1976) 1.02